Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,421) with videos related to
Page
of 143
Sort By:
Ecology and Evolution
|
May 8, 2023
Assessing opportunities and inequities in undergraduate ecological forecasting education
Alyssa M Willson, Hayden Gallo, Jody A Peters, et al.
Gynecologic Oncology
|
September 3, 2021
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer
Katherine C Fuh, Michael A Bookman, Joyce F Liu, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
May 8, 2026
Expanded Biological Characterization of Autograft-Derived Contributions to Spinal Fusion: Graft-Derived Progenitors Contribute via Endochondral Bone Formation
Atsuyuki Kawabata, Duby D Okonkwo, Takuya Oyaizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Siqing Fu, Bradley R Corr, Kerry Culm-Merdek, et al.
Journal of Orthopaedic Trauma
|
July 2, 2019
The Size of Intramedullary Fixation Affects Endochondral-Mediated Angiogenesis During Fracture Repair
Masato Yuasa, Masanori Saito, Deke M Blum, et al.
Brain Injury
|
June 16, 2021
Retrospective analysis of small intracranial hemorrhage in trauma: Is acute care surgery team management alone safe?
Shyam Murali, Farjana Alam, Jenna Kroeker, et al.
Gynecologic Oncology
|
August 14, 2017
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
Premal H Thaker, William E Brady, Heather A Lankes, et al.
Science (New York, N.Y.)
|
February 11, 2000
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice
S K Mani, A A Fienberg, J P O'Callaghan, et al.
Gynecologic Oncology
|
February 3, 2023
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
Lucy Gilbert, Ana Oaknin, Ursula A Matulonis, et al.
JAMA Oncology
|
November 28, 2019
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer
Jyoti S Mayadev, Danielle Enserro, Yvonne G Lin, et al.
Page
of 143
Search research articles
Search
Showing results (1161-1170 of 1,421) with videos related to
Sort By:
Page
of 143
Ecology and Evolution
|
May 8, 2023
Assessing opportunities and inequities in undergraduate ecological forecasting education
Alyssa M Willson, Hayden Gallo, Jody A Peters, et al.
Gynecologic Oncology
|
September 3, 2021
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer
Katherine C Fuh, Michael A Bookman, Joyce F Liu, et al.
The Spine Journal : Official Journal of the North American Spine Society
|
May 8, 2026
Expanded Biological Characterization of Autograft-Derived Contributions to Spinal Fusion: Graft-Derived Progenitors Contribute via Endochondral Bone Formation
Atsuyuki Kawabata, Duby D Okonkwo, Takuya Oyaizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Siqing Fu, Bradley R Corr, Kerry Culm-Merdek, et al.
Journal of Orthopaedic Trauma
|
July 2, 2019
The Size of Intramedullary Fixation Affects Endochondral-Mediated Angiogenesis During Fracture Repair
Masato Yuasa, Masanori Saito, Deke M Blum, et al.
Brain Injury
|
June 16, 2021
Retrospective analysis of small intracranial hemorrhage in trauma: Is acute care surgery team management alone safe?
Shyam Murali, Farjana Alam, Jenna Kroeker, et al.
Gynecologic Oncology
|
August 14, 2017
A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
Premal H Thaker, William E Brady, Heather A Lankes, et al.
Science (New York, N.Y.)
|
February 11, 2000
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice
S K Mani, A A Fienberg, J P O'Callaghan, et al.
Gynecologic Oncology
|
February 3, 2023
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
Lucy Gilbert, Ana Oaknin, Ursula A Matulonis, et al.
JAMA Oncology
|
November 28, 2019
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer
Jyoti S Mayadev, Danielle Enserro, Yvonne G Lin, et al.
Page
of 143